Digital twins in oncology Sebastian Sager Guest Editorial Open access 16 February 2023 Pages: 5475 - 5477
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas Jeronimo Rafael Rodriguez-CidJuan Jose Juarez-Vignon WhaleyDan Green-Renner Research 04 December 2022 Pages: 5479 - 5491
Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma Karin G. SchrenkWolfram WeschenfelderAndreas Hochhaus Research Open access 05 December 2022 Pages: 5493 - 5496
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing Meiling ChengGuodong LiangYang Liu Research 05 December 2022 Pages: 5497 - 5512
Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling Guangchao PanMengya ZhongJie Zha Research 06 December 2022 Pages: 5513 - 5529
X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three identified subsets in resectable adenocarcinoma of the pancreas Karl KnipperSu Ir Lyuthe PANCALYZE Study Group Research Open access 06 December 2022 Pages: 5531 - 5538
Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell lines Myriam BoeschenDiana Le DucSusanne Horn Research Open access 06 December 2022 Pages: 5539 - 5545
IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways Liwei LiuYan ChengBo Liu Research 06 December 2022 Pages: 5547 - 5557
Systematic analysis of mistletoe prescriptions in clinical studies Henrike StaupeJudith BuentzelJutta Huebner Research Open access 09 December 2022 Pages: 5559 - 5571
Impact of patient nationality on the severity of early side effects after radiotherapy Mümtaz KöksalRomy StreppelLeonard C. Schmeel Research Open access 10 December 2022 Pages: 5573 - 5582
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea Jae-Won HyunKi Hoon KimHo Jin Kim Research Open access 10 December 2022 Pages: 5583 - 5589
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study Mara PersanoMargherita RiminiAndrea Casadei-Gardini Research 13 December 2022 Pages: 5591 - 5602
Tumor budding as an indicator for lymph node metastasis and prognosis of early gastric cancer Gaoyan YaoYi FangXiaoyun Ding Research 13 December 2022 Pages: 5603 - 5616
KCMF1 regulates autophagy and ion channels’ function in renal cell carcinoma: a future therapeutic target Ashu SinghSaumitra Dey ChoudhuryAlpana Sharma Research 14 December 2022 Pages: 5617 - 5626
The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma Tian WangDuo ZhangLei Tao Research 15 December 2022 Pages: 5627 - 5636
Impact of physical activity on postural stability and coordination in children with posterior fossa tumor: randomized control phase III trial Mahmoud UsamaFaten AbdelaziemWael Zekri Research Open access 16 December 2022 Pages: 5637 - 5644
Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients Sandra N. FreibergerDavid HolzmannNiels J. Rupp Research Open access 17 December 2022 Pages: 5645 - 5653
Psychosocial distress in young adults surviving hematological malignancies: a pilot study Andreas WittwerKristin SponholzInken Hilgendorf Research Open access 17 December 2022 Pages: 5655 - 5663
Breast cancer therapy in women under 35 years and between 50 and 69 years: influence of the observation period J. SchreiberA. IgnatovH. Eggemann Research 20 December 2022 Pages: 5665 - 5676
Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study Richard van der MeerJudith W. M. JeukenRudi M. H. Roumen Research 21 December 2022 Pages: 5677 - 5685
Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer Nikola ZmarzłySzymon JanuszykDariusz Boroń Research Open access 21 December 2022 Pages: 5687 - 5696
Correlations between antimicrobial peptides and spectrophotometric skin color parameters in patients with basal cell carcinoma Marta FijałkowskaMateusz KoziejAneta Sitek Research Open access 21 December 2022 Pages: 5697 - 5704
Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines Jeongjae LeeBhumsuk KeamDae Seog Heo Research 22 December 2022 Pages: 5705 - 5715
The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma Juan YangYin LiChenggang Li Research 22 December 2022 Pages: 5717 - 5728
High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system Verena Nilius-EliliwiHannes TreiberRoland Schroers Research Open access 24 December 2022 Pages: 5729 - 5732
The usefulness of a three-protein signature blood assay (Mastocheck®) for follow-up after breast cancer surgery Yumi KimHong-Kyu KimDong-Young Noh Research Open access 24 December 2022 Pages: 5733 - 5741
A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer Franka HochhertzPeter HassAhmed Gawish Research Open access 25 December 2022 Pages: 5743 - 5749
The basement membrane-related gene signature is associated with immunity and predicts survival accurately in hepatocellular carcinoma Yu ZhaoZhenjie YinHongbin Chen Research 27 December 2022 Pages: 5751 - 5760
CACYBP knockdown inhibits progression of prostate cancer via p53 Qiang LiZhili LiuKan Zhang Research Open access 28 December 2022 Pages: 5761 - 5772
DOAC in the treatment of cancer-associated venous thromboembolism: a retrospective cohort study beyond the guidelines Mattia CominaciniSilvia SuardiLuca Dalle Carbonare Research Open access 28 December 2022 Pages: 5773 - 5779
Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration Koji TakanoKeiichi AshikariTakuma Higurashi Research 30 December 2022 Pages: 5781 - 5790
The debatable role of immune checkpoint blockade therapy in lung adenocarcinoma-oriented liver metastatic malignant lesions Dan QiuHangtian XiJian Zhang Research 30 December 2022 Pages: 5791 - 5802
Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread Dawid SigorskiWojciech WesołowskiEwa Iżycka-Świeszewska Research Open access 30 December 2022 Pages: 5803 - 5822
Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma Mukesh KumarRamanpreet KaurAnuradha Chakraborti Research 30 December 2022 Pages: 5823 - 5839
Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis Alice SajiManeera ChopraAnusha Thomas Research 31 December 2022 Pages: 5841 - 5852
Impact of breath-hold technique on incidence of cardiac events in adjuvant left breast cancer irradiation Amr A. MahmoudEmad A. SadakaAhmed Gawish Research 31 December 2022 Pages: 5853 - 5859
Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis Mengqi ZhouBinrui YangHenglong Hu Research 31 December 2022 Pages: 5861 - 5869
Identification and validation of a PD-L1-related signature from mass spectrometry in gastric cancer Xiancong ChenDeli MaoChanghua Zhang Research Open access 02 January 2023 Pages: 5871 - 5884
Involvement of angiogenesis in cancer-associated acinar-to-ductal metaplasia lesion of pancreatic cancer invasive front Shuang FeiKenoki OhuchidaMasafumi Nakamura Research 02 January 2023 Pages: 5885 - 5899
Dual-layer spectral detector CT (SDCT) can improve the detection of mixed ground-glass lung nodules Zhenghua ZhangFang YinDan Han Research 03 January 2023 Pages: 5901 - 5906
Bevacizumab biosimilar candidate TAB008 compared to Avastin® in patients with locally advanced, metastatic EGFR wild-type non-squamous non-small cell lung cancer: a randomized, double-blind, multicenter study S. LuS. QinJ. He Research 03 January 2023 Pages: 5907 - 5914
Effect of antimicrobial therapy on progression-free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer Mark UhlenbruchStefan Krüger Research 03 January 2023 Pages: 5915 - 5919
Suppression of exosomal hsa_circ_0001005 eliminates the Vemurafenib resistance of melanoma Xicheng WangQiong Cheng Research 04 January 2023 Pages: 5921 - 5936
Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer Florian LordickPeter Thuss-PatienceÖzlem Türeci Research Open access 06 January 2023 Pages: 5937 - 5950
Prognostic value of MR-detected mandibular nerve involvement: potential indication for future individual induction chemotherapy in T4 nasopharyngeal carcinoma Wenjie HuangShuqi LiLizhi Liu Research Open access 06 January 2023 Pages: 5951 - 5964
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy Mümtaz KöksalLaura KerstingLeonard C. Schmeel Research Open access 06 January 2023 Pages: 5965 - 5973
Using a zebrafish xenograft tumor model to compare the efficacy and safety of VEGFR-TKIs Hou WantingZhong JianCao Dan Research 07 January 2023 Pages: 5975 - 5987
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposure Antonio Pizuorno MachadoMalek ShatilaYinghong Wang Research 08 January 2023 Pages: 5989 - 5998
Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making Liu ShiYuxin LiuXinping Cao Research Open access 09 January 2023 Pages: 5999 - 6007
Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study Sergio Armando Zapata BonillaMarius FriedMartin Eichler Research Open access 10 January 2023 Pages: 6009 - 6021